Last updated: July 17, 2026

Application No. 18/757,296

HIV Specific Binding Molecules and Uses Thereof

Non-Final OA

Filed

Jun 27, 2024

Priority

Feb 20, 2022 — provisional 63/312,077 +1 more

Examiner

CHEONG, CHEOM-GIL

Art Unit

1645

Tech Center

1600 — Biotechnology & Organic Chemistry

Assignee

Immunocore Limited

OA Round

1 (Non-Final)

Interview Optional

— +54.0% interview lift. Interview already conducted in this application's prosecution history. This examiner has a 65% grant rate with +54.0% interview lift. Since an interview has already been tried, recommend written response with narrowed claims based on precedent claim evolution patterns.

Based on 183 resolved cases, 2023–2026

Examiner Intelligence

CHEONG, CHEOM-GIL View full profile →

Grants 65% — above average

Career Allowance Rate

119 granted / 183 resolved

+5.0% vs TC avg

Strong +54% interview lift

Without

With

+54.0%

Interview Lift

resolved cases with interview

Typical timeline

3y 3m

Avg Prosecution

38 currently pending

Career history

214

Total Applications

across all art units

Statute-Specific Performance

§101

2.4%

-37.6% vs TC avg

§103

30.4%

-9.6% vs TC avg

§102

10.9%

-29.1% vs TC avg

§112

20.9%

-19.1% vs TC avg

Black line = Tech Center average estimate • Based on career data from 183 resolved cases

Prosecution Timeline

Jun 27, 2024

Application Filed

Jun 08, 2026

Examiner Interview (Telephonic)

Jun 22, 2026

Non-Final Rejection mailed (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/344,998

Patent 12673078

BACTERIOPHAGES PRODUCING HETEROLOGOUS BACTERIOCINS

3y 0m to grant Granted Jul 07, 2026

17/605,945

Patent 12655189

A DOTA binding chimeric antigen receptor for cellular therapy

4y 7m to grant Granted Jun 16, 2026

16/963,701

Patent 12649798

POLYPEPTIDE VARIANTS AND USES THEREOF

5y 10m to grant Granted Jun 09, 2026

17/953,025

Patent 12636355

TRANSMISSION-BLOCKING VACCINE AGAINST BABESIA

3y 8m to grant Granted May 26, 2026

17/626,955

Patent 12624119

ISOLATED ANTIGEN-BINDING PROTEIN AND APPLICATION THEREOF

4y 4m to grant Granted May 12, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.

Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2

Expected OA Rounds

65%

Grant Probability

99%

With Interview (+54.0%)

3y 3m (~1y 2m remaining)

Median Time to Grant

Low

PTA Risk

Based on 183 resolved cases by this examiner. Grant probability derived from career allowance rate.